Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Jan;75(1):84–90. doi: 10.1172/JCI111701

Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.

W Flameng, F Van de Werf, J Vanhaecke, M Verstraete, D Collen
PMCID: PMC423408  PMID: 4038406

Abstract

Occlusive thrombus was produced by thrombin-induced coagulation in the left anterior descending coronary artery (LAD) of 16 open-chest baboons. In six control animals, occlusive thrombosis persisting over a period of 4 h as evidenced by coronary arteriography resulted in large transmural infarction (63.1 +/- 3.5% of the perfusion area). In 10 animals, tissue-type plasminogen activator obtained by recombinant DNA technology (rt-PA) was infused systemically at a rate of 1,000 IU (10 micrograms)/kg per min for 30 min after 30-80 min of coronary thrombosis. Reperfusion occurred within 30 min in nine animals. In one animal, intravenous infusion was followed by an intracoronary infusion at the same rate, which resulted in thrombolysis within 8 min. In the rt-PA group, mean duration of occlusion before reperfusion was 77 +/- 24 min. Reocclusion occurred in one animal. Recanalization resulted in an overall reduction of infarct size (37.8 +/- 5.9%, P less than 0.05 versus controls). Residual infarction was related to the duration of occlusion (r = 0.80, P less than 0.01). Reperfusion was associated with reduced reflow. Myocardial blood flow in the perfusion area of the LAD was only 70% of normal after 4 h despite perfect angiographic refilling. The infusion of rt-PA was not associated with systemic activation of the fibrinolytic system, fibrinogen breakdown, or clinically evident bleeding. It is concluded that intravenous infusion of rt-PA may recanalize thrombosed coronary vessels without inducing systemic lysis. The extent of residual infarction is closely related to the duration of coronary artery occlusion before thrombolysis.

Full text

PDF
84

Images in this article

86Image
on p.86
86Image
on p.86

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Althaus U., Janett J., Scholl E., Riedwyl H. Effects of myocardial revascularization following acute coronary occlusion in pigs. Eur J Clin Invest. 1976 Jan 30;6(1):7–15. doi: 10.1111/j.1365-2362.1976.tb00487.x. [DOI] [PubMed] [Google Scholar]
  2. Bergmann S. R., Fox K. A., Ter-Pogossian M. M., Sobel B. E., Collen D. Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science. 1983 Jun 10;220(4602):1181–1183. doi: 10.1126/science.6602378. [DOI] [PubMed] [Google Scholar]
  3. Bloor C. M., White F. C. Coronary artery reperfusion: effects of occlusion duration on reactive hyperemia responses. Basic Res Cardiol. 1975 Mar-Apr;70(2):148–158. doi: 10.1007/BF01905616. [DOI] [PubMed] [Google Scholar]
  4. Bresnahan G. F., Roberts R., Shell W. E., Ross J., Jr, Sobel B. E. Deleterious effects due to hemorrhage after myocardial reperfusion. Am J Cardiol. 1974 Jan;33(1):82–86. doi: 10.1016/0002-9149(74)90742-5. [DOI] [PubMed] [Google Scholar]
  5. Buckberg G. D., Luck J. C., Payne D. B., Hoffman J. I., Archie J. P., Fixler D. E. Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol. 1971 Oct;31(4):598–604. doi: 10.1152/jappl.1971.31.4.598. [DOI] [PubMed] [Google Scholar]
  6. Campbell C. D., Takanashi Y., Laas J., Meus P., Pick R., Replogle R. L. Effect of coronary artery reperfusion on infarct size in swine. J Thorac Cardiovasc Surg. 1981 Feb;81(2):288–296. [PubMed] [Google Scholar]
  7. Capone R. J., Most A. S. Myocardial hemorrhage after coronary reperfusion in pigs. Am J Cardiol. 1978 Feb;41(2):259–266. doi: 10.1016/0002-9149(78)90164-9. [DOI] [PubMed] [Google Scholar]
  8. Collen D., Rijken D. C., Van Damme J., Billiau A. Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo. Thromb Haemost. 1982 Dec 27;48(3):294–296. [PubMed] [Google Scholar]
  9. Collen D., Stassen J. M., Marafino B. J., Jr, Builder S., De Cock F., Ogez J., Tajiri D., Pennica D., Bennett W. F., Salwa J. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. J Pharmacol Exp Ther. 1984 Oct;231(1):146–152. [PubMed] [Google Scholar]
  10. Collen D., Stassen J. M., Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. J Clin Invest. 1983 Feb;71(2):368–376. doi: 10.1172/JCI110778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Costantino C., Corday E., Lang T. W., Meerbaum S., Brasch J., Kaplan L., Rubins S., Gold H., Osher J. Revascularization after 3 hours of coronary arterial occlusion: effects on regional cardiac metabolic function and infarct size. Am J Cardiol. 1975 Sep;36(3):368–384. doi: 10.1016/0002-9149(75)90492-0. [DOI] [PubMed] [Google Scholar]
  12. Crozatier B., Ross J., Jr, Franklin D., Bloor C. M., White F. C., Tomoike H., McKown D. P. Myocardial infarction in the baboon: regional function and the collateral circulation. Am J Physiol. 1978 Oct;235(4):H413–H421. doi: 10.1152/ajpheart.1978.235.4.H413. [DOI] [PubMed] [Google Scholar]
  13. Fishbein M. C., Meerbaum S., Rit J., Lando U., Kanmatsuse K., Mercier J. C., Corday E., Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981 May;101(5):593–600. doi: 10.1016/0002-8703(81)90226-x. [DOI] [PubMed] [Google Scholar]
  14. Fishbein M. C., Y-Rit J., Lando U., Kanmatsuse K., Mercier J. C., Ganz W. The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Circulation. 1980 Dec;62(6):1274–1279. doi: 10.1161/01.cir.62.6.1274. [DOI] [PubMed] [Google Scholar]
  15. Geary G. G., Smith G. T., McNamara J. J. Quantitative effect of early coronary artery reperfusion in baboons. Extent of salvage of the perfusion bed of an occluded artery. Circulation. 1982 Aug;66(2):391–396. doi: 10.1161/01.cir.66.2.391. [DOI] [PubMed] [Google Scholar]
  16. Ginks W. R., Sybers H. D., Maroko P. R., Covell J. W., Sobel B. E., Ross J., Jr Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest. 1972 Oct;51(10):2717–2723. doi: 10.1172/JCI107091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Heyndrickx G. R., Millard R. W., McRitchie R. J., Maroko P. R., Vatner S. F. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest. 1975 Oct;56(4):978–985. doi: 10.1172/JCI108178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Higginson L. A., White F., Heggtveit H. A., Sanders T. M., Bloor C. M., Covell J. W. Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog. Circulation. 1982 Jan;65(1):62–69. doi: 10.1161/01.cir.65.1.62. [DOI] [PubMed] [Google Scholar]
  19. Korninger C., Matsuo O., Suy R., Stassen J. M., Collen D. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis. J Clin Invest. 1982 Mar;69(3):573–580. doi: 10.1172/JCI110483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lang T. W., Corday E., Gold H., Meerbaum S., Rubins S., Costantini C., Hirose S., Osher J., Rosen V. Consequences of reperfusion after coronary occlusion. Effects on hemodynamic and regional myocardial metabolic function. Am J Cardiol. 1974 Jan;33(1):69–81. doi: 10.1016/0002-9149(74)90741-3. [DOI] [PubMed] [Google Scholar]
  21. Lubbe W. F., Peisach M., Pretorius R., Bruyneel K. J., Opie L. H. Distribution of myocardial blood flow before and after coronary artery ligation in the baboon. Relation to early ventricular fibrillation. Cardiovasc Res. 1974 Jul;8(4):478–487. doi: 10.1093/cvr/8.4.478. [DOI] [PubMed] [Google Scholar]
  22. Maroko P. R., Libby P., Ginks W. R., Bloor C. M., Shell W. E., Sobel B. E., Ross J., Jr Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest. 1972 Oct;51(10):2710–2716. doi: 10.1172/JCI107090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mathur V. S., Guinn G. A., Burris W. H., 3rd Maximal revascularization (reperfusion) in intact conscious dogs after 2 to 5 hours of coronary occlusion. Am J Cardiol. 1975 Aug;36(2):252–261. doi: 10.1016/0002-9149(75)90534-2. [DOI] [PubMed] [Google Scholar]
  24. Matsuo O., Rijken D. C., Collen D. Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Nature. 1981 Jun 18;291(5816):590–591. doi: 10.1038/291590a0. [DOI] [PubMed] [Google Scholar]
  25. Pennica D., Holmes W. E., Kohr W. J., Harkins R. N., Vehar G. A., Ward C. A., Bennett W. F., Yelverton E., Seeburg P. H., Heyneker H. L. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature. 1983 Jan 20;301(5897):214–221. doi: 10.1038/301214a0. [DOI] [PubMed] [Google Scholar]
  26. Reimer K. A., Jennings R. B. The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation. Circulation. 1979 Oct;60(4):866–876. doi: 10.1161/01.cir.60.4.866. [DOI] [PubMed] [Google Scholar]
  27. Roberts C. S., Schoen F. J., Kloner R. A. Effect of coronary reperfusion on myocardial hemorrhage and infarct healing. Am J Cardiol. 1983 Sep 1;52(5):610–614. doi: 10.1016/0002-9149(83)90036-x. [DOI] [PubMed] [Google Scholar]
  28. Schaper W., Flameng W., Winkler B., Wüsten B., Türschmann W., Neugebauer G., Carl M., Pasyk S. Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog. Circ Res. 1976 Sep;39(3):371–377. doi: 10.1161/01.res.39.3.371. [DOI] [PubMed] [Google Scholar]
  29. Schwarz F., Wagner H. O., Sesto M., Hofmann M., Schaper W., Kübler W. Native collaterals in the development of collateral circulation after chronic coronary stenosis in mongrel dogs. Circulation. 1982 Aug;66(2):303–308. doi: 10.1161/01.cir.66.2.303. [DOI] [PubMed] [Google Scholar]
  30. Smith G. T., Soeter J. R., Haston H. H., McNamara J. J. Coronary reperfusion in primates. Serial electrocardiographic and histologic assessment. J Clin Invest. 1974 Dec;54(6):1420–1427. doi: 10.1172/JCI107889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Van de Werf F., Bergmann S. R., Fox K. A., de Geest H., Hoyng C. F., Sobel B. E., Collen D. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. Circulation. 1984 Mar;69(3):605–610. doi: 10.1161/01.cir.69.3.605. [DOI] [PubMed] [Google Scholar]
  32. Weimar W., Stibbe J., van Seyen A. J., Billiau A., De Somer P., Collen D. Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator. Lancet. 1981 Nov 7;2(8254):1018–1020. doi: 10.1016/s0140-6736(81)91217-4. [DOI] [PubMed] [Google Scholar]
  33. White F. C., Sanders M., Bloor C. M. Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. Am J Cardiol. 1978 Aug;42(2):234–243. doi: 10.1016/0002-9149(78)90905-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES